Back to top

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The study, officially titled “A Single- and Multiple-Ascending Do...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Eli Lilly and Company (LLY)